Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children. Agency scientists said 46 cancer cases and 71 infection cases have been reported in patients aged 16 and younger from 2004 to 2008 with Novartis' Elidel and Astellas' Protopic.
Thursday, March 18, 2010
Great, now we have to worry about cancer
Guess I should stop using that tube of Protopic.
Subscribe to:
Posts (Atom)